Racial differences in the prevalence of Factor V Leiden mutation among patients on chronic warfarin therapy.

doi:10.1016/j.bcmd.2006.06.003

Article

Racial differences in the prevalence of Factor V Leiden mutation among patients on chronic warfarin therapy.

Blood cells, molecules & diseases - 1 Jan 2000

Limdi N A, Beasley T M, Allison D B, Rivers C A, Acton R T

Abstract excerpt

We report the prevalence of Factor V Leiden (FVL) in European American and African American patients on warfarin therapy residing in Alabama. METHODS.: Detailed history was obtained and FVL genotype was determined for 288 patients enrolled in a prospective cohort: Pharmacogenetic Optimization of Anticoagulation Therapy. Racial differences in genotype frequency were assessed by the Chi-square statistics and HWE...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Racial differences in the prevalence of Factor V Leiden mutation among patients on chronic warfarin therapy.

Abstract excerpt

Topics

Related research